Literature DB >> 12732720

Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression.

Malika El Yacoubi1, Saoussen Bouali, Daniela Popa, Laurent Naudon, Isabelle Leroux-Nicollet, Michel Hamon, Jean Costentin, Joëlle Adrien, Jean-Marie Vaugeois.   

Abstract

Depression is a multifactorial illness and genetic factors play a role in its etiology. The understanding of its physiopathology relies on the availability of experimental models potentially mimicking the disease. Here we describe a model built up by selective breeding of mice with strikingly different responses in the tail suspension test, a stress paradigm aimed at screening potential antidepressants. Indeed, "helpless" mice are essentially immobile in the tail suspension test, as well as the Porsolt forced-swim test, and they show reduced consumption of a palatable 2% sucrose solution. In addition, helpless mice exhibit sleep-wakefulness alterations resembling those classically observed in depressed patients, notably a lighter and more fragmented sleep, with an increased pressure of rapid eye movement sleep. Compared with "nonhelpless" mice, they display higher basal seric corticosterone levels and lower serotonin metabolism index in the hippocampus. Remarkably, serotonin(1A) autoreceptor stimulation induces larger hypothermia and inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis in helpless than in nonhelpless mice. Thus, helpless mice exhibit a decrease in serotoninergic tone, which evokes that associated with endogenous depression in humans. Finally, both the behavioral impairments and the serotoninergic dysfunction can be improved by chronic treatment with the antidepressant fluoxetine. The helpless line of mice may provide an opportunity to approach genes influencing susceptibility to depression and to investigate neurophysiological and neurochemical substrates underlying antidepressant effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732720      PMCID: PMC156354          DOI: 10.1073/pnas.1034823100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.

Authors:  Q Li; C Wichems; A Heils; K P Lesch; D L Murphy
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice.

Authors:  Takeo Yoshikawa; Akiko Watanabe; Yuichi Ishitsuka; Akihiro Nakaya; Noriaki Nakatani
Journal:  Genome Res       Date:  2002-03       Impact factor: 9.043

Review 3.  Assessing antidepressant activity in rodents: recent developments and future needs.

Authors:  John F Cryan; Athina Markou; Irwin Lucki
Journal:  Trends Pharmacol Sci       Date:  2002-05       Impact factor: 14.819

Review 4.  Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists.

Authors:  David H Overstreet
Journal:  Behav Genet       Date:  2002-09       Impact factor: 2.805

Review 5.  History and evolution of the monoamine hypothesis of depression.

Authors:  R M Hirschfeld
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

6.  GENESiS: creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings.

Authors:  P C Sham; A Sterne; S Purcell; S Cherny; M Webster; F Rijsdijk; P Asherson; D Ball; I Craig; T Eley; D Goldberg; J Gray; A Mann; M Owen; R Plomin
Journal:  Twin Res       Date:  2000-12

7.  5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.

Authors:  A Evrard; A M Laporte; M Chastanet; R Hen; M Hamon; J Adrien
Journal:  Eur J Neurosci       Date:  1999-11       Impact factor: 3.386

8.  High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations.

Authors:  C Dugovic; S Maccari; L Weibel; F W Turek; O Van Reeth
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

9.  A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.

Authors:  Laurent Naudon; Malika El Yacoubi; Jean-Marie Vaugeois; Isabelle Leroux-Nicollet; Jean Costentin
Journal:  Brain Res       Date:  2002-05-17       Impact factor: 3.252

10.  QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice.

Authors:  M G Turri; S R Datta; J DeFries; N D Henderson; J Flint
Journal:  Curr Biol       Date:  2001-05-15       Impact factor: 10.834

View more
  70 in total

1.  Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions.

Authors:  Giovanna Piras; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

2.  Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor.

Authors:  Xiaojun Wu; Hung Hsuchou; Abba J Kastin; Yi He; Reas S Khan; Kirsten P Stone; Michael S Cash; Weihong Pan
Journal:  Psychoneuroendocrinology       Date:  2010-08-17       Impact factor: 4.905

3.  Evaluation of reward processes in an animal model of depression.

Authors:  David A Slattery; Athina Markou; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2006-12-20       Impact factor: 4.530

4.  Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression.

Authors:  Giovanna Piras; Maria A Piludu; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2013-07-30       Impact factor: 4.530

5.  Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level.

Authors:  Elisabeth Barbier; Jia Bei Wang
Journal:  BMC Neurosci       Date:  2009-11-13       Impact factor: 3.288

6.  TASK-3 as a potential antidepressant target.

Authors:  Anthony L Gotter; Vincent P Santarelli; Scott M Doran; Pamela L Tannenbaum; Richard L Kraus; Thomas W Rosahl; Hamid Meziane; Marina Montial; Duane R Reiss; Keith Wessner; Alexander McCampbell; Joanne Stevens; Joseph I Brunner; Steven V Fox; Victor N Uebele; Douglas A Bayliss; Christopher J Winrow; John J Renger
Journal:  Brain Res       Date:  2011-08-16       Impact factor: 3.252

7.  Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.

Authors:  Thibault Renoir; Terence Y C Pang; Michelle S Zajac; Grace Chan; Xin Du; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

8.  Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia.

Authors:  Ashley M Fenn; John C Gensel; Yan Huang; Phillip G Popovich; Jonathan Lifshitz; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-10-25       Impact factor: 13.382

9.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

10.  Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.

Authors:  Abigail G Schindler; Daniel I Messinger; Jeffrey S Smith; Haripriya Shankar; Richard M Gustin; Selena S Schattauer; Julia C Lemos; Nicholas W Chavkin; Catherine E Hagan; John F Neumaier; Charles Chavkin
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.